Patents by Inventor Piotr Cmoch

Piotr Cmoch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Protoescigenin derivative, process of its preparation, use of said compound and pharmaceutical composition comprising that compound
    Patent number: 10370404
    Abstract: Described herein is compound including a protoescigenin derivative having pharmacological properties. Also described are a process of its preparation, and the use of such a compound as a medicament, especially for treating vascular disorders. A pharmaceutical composition comprising such compound is further described.
    Type: Grant
    Filed: February 26, 2016
    Date of Patent: August 6, 2019
    Assignee: Warszawski Uniwersytet Medyczny
    Inventors: Katarzyna Koziak, Krzysztof Bojakowski, Magdalena Kowalewska, Dorota Maciejko, Oliwia Zegrocka-Stendel, Iwona Grabowska, Grzegorz Grynkiewicz, Mariusz Marek Gruza, Kamil Jatczak, Katarzyna Filip, Piotr Cmoch, Marta Laszcz, Malgorzata Dutkiewicz
  • PROTOESCIGENIN DERIVATIVE, PROCESS OF ITS PREPARATION, USE OF SAID COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING THAT COMPOUND
    Publication number: 20180244714
    Abstract: Described herein is compound including a protoescigenin derivative having pharmacological properties. Also described are a process of its preparation, and the use of such a compound as a medicament, especially for treating vascular disorders. A pharmaceutical composition comprising such compound is further described.
    Type: Application
    Filed: February 26, 2016
    Publication date: August 30, 2018
    Inventors: Katarzyna Koziak, Krzysztof Bojakowski, Magdalena Kowalewska, Dorota Maciejko, Oliwia Zegrocka-Stendel, Iwona Grabowska, Grzegorz Grynkiewicz, Mariusz Marek Gruza, Kamil Jatczak, Katarzyna Filip, Piotr Cmoch, Marta Laszcz
  • PROCESS FOR PREPARATION OF PROSTAGLANDIN F2 ALPHA ANALOGUES
    Publication number: 20150031898
    Abstract: A convergent synthesis of the prostaglandin F2? analogues, travoprost and bimatoprost, was developed employing Julia-Lythgoe olefination of the structurally advanced phenylsulfone with an enantiomerically pure aldehyde ?-chain synthon. The novel convergent strategy allows the synthesis of a whole series of prostaglandin analogues of high purity from a common and structurally advanced prostaglandin intermediate.
    Type: Application
    Filed: March 8, 2013
    Publication date: January 29, 2015
    Applicant: INSTYTUT FARMACEUTYCZNY
    Inventors: Iwona Dams, Andrzej Kutner, Michal Chodynski, Malgorzata Krupa, Anita Pietraszek, Marta Zezula, Piotr Cmoch, Monika Kosinska
  • Crystalline polymorphs of methanesulfonic acid addition salts of Imatinib
    Patent number: 7732601
    Abstract: This invention relates to the methanesulfonic acid addition salts of Imatinib and to the synthesis thereof. In particular, this invention relates to the synthesis of crystalline ?-form of Imatinib methanesulfonate. Furthermore, the invention is directed to a novel acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-[(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]benzamide with two molecules of methanesulfonic acid and to the polymorphic forms thereof, as well as to their pharmaceutical compositions.
    Type: Grant
    Filed: April 2, 2005
    Date of Patent: June 8, 2010
    Assignee: Instytut Farmaceutyczny
    Inventors: Wojciech Szczepek, Dorota Samson-Lazinska, Bogdan Zagrodzki, Magdalena Glice, Wioleta Maruszak, Katarzyna Korczak, Ryszard Modzelewski, Marta Lawecka, Lukasz Kaczmarek, Wieslaw Szelejewski, Urszula Fraczek, Piotr Cmoch
  • Crystalline Polymorphs Of Methanesulfonic Acid Addition Salts Of Imatinib
    Publication number: 20070197545
    Abstract: This invention relates to the methanesulfonic acid addition salts of Imatinib and to the synthesis thereof. In particular, this invention relates to the synthesis of crystalline ?-form of Imatinib methanesulfonate. Furthermore, the invention is directed to a novel acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-[(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]benzamide with two molecules of methanesulfonic acid and to the polymorphic forms thereof, as well as to their pharmaceutical compositions.
    Type: Application
    Filed: April 2, 2005
    Publication date: August 23, 2007
    Applicant: INSTYTUT FARMACEUTYCZNY
    Inventors: Wojciech Szczepek, Dorota Samson-Lazinska, Bogdan Zagrodzki, Magdalena Glice, Wioleta Maruszak, Kataryzna Korczak, Ryszard Modzelewski, Marta Lawecka, Lukasz Kaczmarek, Wieslaw Szelejewski, Urszula Fraczek, Piotr Cmoch